expected

CLEO Welcomes former Binance NFT Director Ryan Horn as Global Partnerships Lead

Source Node:
Time Stamp: April 16, 2024 6:00 AM - Modified On: April 16, 2024 - Published By:
Source Cluster:
Republished By Plato

  CLEO, a pioneering RWA (real world asset) technology platform leveraging Web3 to fuse real-world impact with digital asset utility and NFTs, proudly announces the addition of Ryan Horn to its team. As the former Binance NFT Director and a recognized leader in the realms of sports, entertainment, and brand crypto strategies, Ryan will serve as a key advisor and lead for global partnerships. Launched in 2023 with its Marketing for Good proposition (rewarding a prospect’s attention for a tokenized good in the world) and having already onboarded clients such

Moxy.io Welcomes Former UBS CFO Thomas Gustinis to Its Executive Team and to the board of the Moxy Foundation

Source Node:
Time Stamp: April 10, 2024 2:27 PM - Modified On: April 10, 2024 - Published By:
Source Cluster:
Republished By Plato

Zug, Switzerland – Moxy.io proudly announces the appointment of Thomas Gustinis, a key figure in treasury management of UBS, as its previous Global Chief Financial Officer. This landmark hire underscores Moxy.io’s ambition to fortify its leadership team with unparalleled financial expertise and vision, propelling the company towards new horizons in the competitive blockchain and gaming industries. Thomas Gustinis brings to Moxy.io a storied career in global finance, having helmed UBS's treasury operations, where he was instrumental in steering the banking giant through complex financial landscapes and maximizing operational efficiency and

Crypto.com’s Dubai Entity Receives Full Operational Approval

Source Node:
Time Stamp: April 10, 2024 9:43 AM - Modified On: April 10, 2024 - Published By:
Source Cluster:
Republished By Plato

Crypto.com Exchange for Institutional Investors Launches as First Operational Milestone April 9, 2024, Dubai - Crypto.com, trusted by more than 80 million customers worldwide and the industry leader in regulatory compliance, security and privacy, announced today that its Dubai entity, CRO DAX Middle East FZE, has received full operational approval from Dubai’s Virtual Assets Regulatory Authority (VARA) and is launching the Crypto.com Exchange for institutional investors as its first operational milestone. This operational approval follows Crypto.com’s fulfillment of the pre-operational conditions stipulated in the Virtual Asset Service Provider Licence granted

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:23 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

Short Trading: A comprehensive analysis of the controversial strategy and an in-depth analysis of how investors make money from market declines

Source Node:
Time Stamp: March 19, 2024 8:45 AM - Modified On: March 19, 2024 - Published By:
Source Cluster:
Republished By Plato

Short trading is a strategy in which investors make money by taking advantage of predictions that a stock or other asset is expected to fall. The process involves borrowing shares and selling them immediately in the hope of buying them back at a lower price once their price drops, profiting from the difference between the selling and buying prices. Simply put, short trading is a way for investors to make profits through expected negative changes in the market. The Historical Origins of Short Trading The idea of ​​short trading can

Moxy.io Announces Strategic Investment from GDA Capital; Michael Gord to Lead Web3 Initiatives

Source Node:
Time Stamp: March 6, 2024 11:45 AM - Modified On: March 6, 2024 - Published By:
Source Cluster:
Republished By Plato

  Seattle, United States. Moxy.io, a blockchain powered tournament platform and infrastructure provider in the competitive gaming and web3 space, has officially announced a strategic investment from GDA Capital, a leading global digital asset and blockchain investment and capital markets advisory firm. This investment marks a significant milestone for Moxy, as Michael Gord, Founder and CEO of GDA Capital, will also be joining their team as the Head of Web3. Michael Gord's appointment is a testament to the depth of GDA Capital's involvement in Moxy's future. Gord, a seasoned web3

Hard Forks, Soft Forks, Defaults and Coercion

Source Node:
Time Stamp: February 20, 2024 1:15 PM - Modified On: February 20, 2024 - Published By:
Source Cluster:
Republished By Plato

One of the important arguments in the blockchain space is that of whether hard forks or soft forks are the preferred protocol upgrade mechanism. The basic difference between the two is that soft forks change the rules of a protocol by strictly reducing the set of transactions that is valid, so nodes following the old rules will still get on the new chain (provided that the majority of miners/validators implements the fork), whereas hard forks allow previously invalid transactions and blocks to become valid, so clients must upgrade their clients

Verofax facilitates Egyptian EU Export with CBAM Compliance and Lifecycle Assessment Solutions

Source Node:
Time Stamp: February 15, 2024 11:49 AM - Modified On: February 15, 2024 - Published By:
Source Cluster:
Republished By Plato

  Egyptian Businessmen's Association (EBA) convenes export symposium on February 9 CAIRO, Feb 15, 2024 - (ACN Newswire) - The Egyptian Businessmen's Association (EBA) convened a symposium on February 9, chaired by Engineer Majd al-Din al-Manzalawi, Secretary-General and Chairman of the Association’s Industry and Scientific Research Committee, to address the challenges and opportunities presented by the Carbon Border Adjustment Mechanism (CBAM), a law governing manufacturing standards for Egyptian exporters. [caption id="attachment_2481553" align="alignnone" width="780"] The Egyptian Businessmen's Association (EBA) convened to discuss the importance of technology in keeping factories compliant with export

Bitcoin, which goes hand in hand with AI technology, can we expect a continued bright outlook? 

Source Node:
Time Stamp: January 11, 2024 11:30 AM - Modified On: January 11, 2024 - Published By:
Source Cluster:
Republished By Plato

Due to the full-scale introduction of AI technology in 2023, America's big tech companies such as Meta, Amazon, and Twitter are threatening human jobs by laying off more than 100,000 employees a year alone. In the aftermath of this, some experts say that the pace of AI development should be slowed down to prevent further harm to human jobs, but on the other hand, most experts believe that human development should proceed together in a society that coexists with AI, rather than slowing it down. There was also an opinion

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial